Filtered By:
Specialty: Neurology
Education: Study
Management: Medicaid

This page shows you your search results in order of date.

Order by Relevance | Date

Total 26 results found since Jan 2013.

Inequities in Telemedicine Use Among Patients With Stroke and Cerebrovascular Diseases: A Tricenter Cross-sectional Study
Discussion In our diverse cohort across 3 centers, we found differences in TM visit type by race and insurance early during the COVID-19 pandemic. These findings suggest disparities in VTM access across different stroke populations. As VTM remains an integral part of outpatient neurology practice, steps to ensure equitable access are essential.
Source: Neurology Clinical Practice - March 14, 2023 Category: Neurology Authors: Naqvi, I. A., Cohen, A. S., Kim, Y., Harris, J., Denny, M. C., Strobino, K., Bicher, N., Leite, R. A., Sadowsky, D., Adegboye, C., Okpala, N., Okpala, M., Savitz, S. I., Marshall, R. S., Sharrief, A. Tags: All Health Services Research, All Cerebrovascular disease/Stroke, Underserved populations, Health disparities Research Article Source Type: research

Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder
ConclusionUsing large US claims data, we found no evidence of increased SCV risk in children and adolescents with ADHD or ASD exposed to ADHD medications.
Source: CNS Drugs - November 24, 2019 Category: Neurology Source Type: research

Retention of Stroke Education Provided during Hospitalization: Does Provision of Required Education Increase Stroke Knowledge?
Discussion: While stroke education is required during hospitalization, its ability to produce retention may be poor. We propose study of test-enhanced learning methods through the Targeted Education in Stroke Trial (TEST) to examine the effect of novel teaching methods on patient/caregiver knowledge retention.Intervent Neurol 2018;7:471 –478
Source: Interventional Neurology - July 26, 2018 Category: Neurology Source Type: research

Cost of Alteplase Has More Than Doubled Over the Past Decade Brief Report
Conclusions—We found a striking increase in the cost of alteplase over the last decade, with a 100 mg vial now with a CMS payment of ≈$6400, a>100% increase over 10 years. During the same time frame, the DRG base payment to hospitals increased by only 8%, and alteplase cost increased from 27% of the payment in 2006 to 53% in 2013. Researchers and stroke physicians should be aware of these changes in drug costs and their impact on cost-effectiveness analyses.
Source: Stroke - June 26, 2017 Category: Neurology Authors: Dawn Kleindorfer, Joseph Broderick, Bart Demaerschalk, Jeffrey Saver Tags: Cost-Effectiveness, Ischemic Stroke Brief Reports Source Type: research

Early transition to comfort measures only in acute stroke patients: Analysis from the Get With The Guidelines-Stroke registry
Conclusions: Early CMO was utilized in about 5% of stroke patients, being more common in ICH and SAH than IS. Early CMO use varies widely between hospitals and is influenced by patient and hospital characteristics.
Source: Neurology Clinical Practice - June 12, 2017 Category: Neurology Authors: Prabhakaran, S., Cox, M., Lytle, B., Schulte, P. J., Xian, Y., Zahuranec, D., Smith, E. E., Reeves, M., Fonarow, G. C., Schwamm, L. H. Tags: All Cerebrovascular disease/Stroke, Palliative care Research Source Type: research

Disparities in Delivery of Endovascular Therapy: The Florida Puerto Rico Collaboration to Reduce Stroke Disparities Study (CReSD) (S19.003)
Conclusions:There are significant race, regional and hospital disparities in delivery of endovascular care. Efforts should be made to improve access to endovascular treatment to all eligible patients.Disclosure: Dr. Asdaghi has nothing to disclose. Dr. Granzoti Cintra has nothing to disclose. Dr. Wang has nothing to disclose. Dr. Dong has nothing to disclose. Dr. Ciliberti-Vargas has nothing to disclose. Dr. Gutierrez has nothing to disclose. Dr. Koch has nothing to disclose. Dr. Gardener has nothing to disclose. Dr. Marulanda-Londoño has nothing to disclose. Dr. Mueller has nothing to disclose. Dr. Yavagal has rece...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Asdaghi, N., Cintra, L. G., Wang, K., Dong, C., Ciliberti-Vargas, M. A., Gutierrez, C. M., Koch, S., Gardener, H., Marulanda-Londono, E., Mueller, N., Yavagal, D., Mehta, B., Hanel, R., Rose, D. Z., Waddy, S. P., Robichaux, M., Foster, D., Zevallos, J. C. Tags: Best Of: Cerbrovascular Disease and Interventional Neurology Source Type: research

Association between Demographic Characteristics and Hospital Admission in Patients Presenting to the Emergency Department for Transient Neurological Attack (P6.277)
Conclusions:Among patients presenting to the ED with TNA, female sex and race are associated with decreased odds of admission, even after adjusting for socioeconomic and vascular risk factors. Further studies are warranted to determine the public health impact of our results.Disclosure: Dr. Kummer has nothing to disclose. Dr. Parikh has nothing to disclose. Dr. Merkler has nothing to disclose. Dr. Kamel has received personal compensation for activities with Genentech as a speaker. Dr. Kamel has received personal compensation in an editorial capacity for Journal Watch Neurology.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Kummer, B., Parikh, N., Merkler, A., Kamel, H. Tags: Cerebrovascular Disease Health Services Research Source Type: research

Derivation and Validation of a Proposed Long Length of Stay (>= 7 days) Score in Patients Hospitalized for Acute Ischemic Stroke (P1.067)
Conclusions:Many factors play a role in determining the length of stay for AIS patients. Our study provides a scoring system that may help physicians predict which patients are more likely to have a prolonged hospital stay.Disclosure: Dr. Mahmood has nothing to disclose. Dr. Ali has nothing to disclose. Dr. Chauhan has nothing to disclose. Dr. Bianchi has nothing to disclose. Dr. Singhal has received personal compensation for activities with Medicolegal, ACTION Trial Stroke, Biogen, and Dock Technologies. Dr. Singhal holds stock and/or stock options in Biogen. Dr. Singhal has received research support from Boehringer Ingel...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Mahmood, S., Ali, S., Chauhan, M. A., Bianchi, N., Singhal, A., Schwamm, L. Tags: Practice, Policy, and Ethics I Source Type: research

Prevalence of epilepsy/seizures as a comorbidity of neurologic disorders in nursing homes
Conclusions: The prevalence of epi/sz in the elderly nursing home population is >7-fold higher compared to community-dwelling elderly and is 7 to 30 times higher among those with certain comorbid neurologic conditions. Demographics and clinical characteristics had weaker associations with epi/sz prevalence.
Source: Neurology - February 19, 2017 Category: Neurology Authors: Birnbaum, A. K., Leppik, I. E., Svensden, K., Eberly, L. E. Tags: All Cerebrovascular disease/Stroke, All Cognitive Disorders/Dementia, Brain trauma, Prevalence studies, All Epilepsy/Seizures ARTICLE Source Type: research

Recombinant Tissue Plasminogen Activator Stroke Therapy
The results of recently completed clinical trials of acute ischemic stroke that report a clear and unequivocal benefit of stent-retriever devices used with intravenous recombinant tissue plasminogen activator (rtPA) vs rtPA alone are the second revolutionary therapeutic breakthrough in acute stroke care in the last 50 years. This breakthrough makes the case for a new standard of care for the treatment of acute ischemic stroke. When we look back at the controversy surrounding interventional acute stroke therapies after multiple trials of interventional treatment, most notably International Management of Stroke III (IMS III)...
Source: JAMA Neurology - January 25, 2016 Category: Neurology Source Type: research

Analysis of 30 Day Unexpected Readmission Rates in Stroke Patients at an Academic Acute-care Hospital (P5.151)
CONCLUSIONS:SNFs accounted for the greatest percentage of unexpected stroke patient readmissions occurring within 30 days, while IR accounted for none. Main readmitting causes included cerebrovascular, cardiovascular, infections, and dehydration. 70[percnt] of readmissions were geriatric patients. Study Supported by: None.Disclosure: Dr. Kushner has nothing to disclose. Dr. Kelly has nothing to disclose. Dr. Morrison has nothing to disclose. Dr. Camfield has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Kushner, D., Kelly, E., Morrison, R., Camfield, K. Tags: Cerebrovascular Disease and Interventional Neurology: Quality Research and Initiatives Source Type: research

Rate and Risk Factors of Recurrent 30-Day Readmissions following Hospitalization for Ischemic Stroke (S47.003)
CONCLUSIONS: Patients with 30-day readmissions after index hospitalization for ischemic stroke remain at further risk for recurrent 30-day readmissions. Characterization of magnitude and risk factors of recurrent 30-day readmissions may provide framework for reducing such preventable readmissions.Disclosure: Dr. Moradiya has nothing to disclose. Dr. Murthy has nothing to disclose. Dr. Modi has nothing to disclose. Dr. Naval has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Moradiya, Y., Murthy, S., Modi, S., Naval, N. Tags: Cerebrovascular Disease and Interventional Neurology Source Type: research

Are Treatment Preferences of Those Who Died Ever Heard?: The Lack of Documentation of Preferences in a State-Wide Cohort of Patients Who Died Following Ischemic Stroke (S47.004)
CONCLUSIONS: Among a representative sample of California patients who died within 30 days after an ischemic stroke, less than half had documented discussions about LSI. The new Medicare policy could serve as an additional barrier to increasing communication about preferences, as physicians may fear that these discussions would lead to withdrawal of LSI, increased 30-day mortality, and thus misleading estimates of the hospital’s quality of care. Study Supported by:California OSHPD, RWJCSPDisclosure: Dr. Robinson has nothing to disclose. Dr. Vickrey has received personal compensation for activities with EMD Serono as a...
Source: Neurology - April 8, 2015 Category: Neurology Authors: Robinson, M., Vickrey, B., Holloway, R., Chong, K., Williams, L., Parikh, P., Leng, M., Zingmond, D. Tags: Cerebrovascular Disease and Interventional Neurology Source Type: research

Early improvement after IV tPA at the largest safety-net hospital in New England: the Boston Medical Center experience (P6.232)
CONCLUSIONS: Neurologic improvement within 24 hours was seen in half of our cohort. Patients who improved benefited despite high baseline NIHSS scores and multiple comorbidities. Interestingly time to needle onset was not a significant predictor for early improvement. Further efforts to include underserved populations in clinical trials should be undertaken to clarify key predictors of early improvement after tPA infusion in this population.Disclosure: Dr. Tawakul has nothing to disclose. Dr. Ge has nothing to disclose. Dr. Lau has nothing to disclose. Dr. Nguyen has nothing to disclose. Dr. Romero has nothing to disclose....
Source: Neurology - April 8, 2015 Category: Neurology Authors: Tawakul, A., Ge, G., Lau, H., Nguyen, T., Romero, J., Babikian, V., Kase, C., Masoud, H. Tags: Cerebrovascular Disease and Interventional Neurology: Acute Thrombolysis Source Type: research

Comparative Risk of Ischemic Stroke Among Users of Clopidogrel Together With Individual Proton Pump Inhibitors Clinical Sciences
Conclusions— PPIs of interest did not increase the rate of ischemic stroke among clopidogrel users when compared with pantoprazole, a PPI thought to be devoid of the potential to interact with clopidogrel.
Source: Stroke - February 23, 2015 Category: Neurology Authors: Leonard, C. E., Bilker, W. B., Brensinger, C. M., Flockhart, D. A., Freeman, C. P., Kasner, S. E., Kimmel, S. E., Hennessy, S. Tags: Platelet function inhibitors, Acute Cerebral Infarction, Acute Stroke Syndromes, Antiplatelets, Epidemiology Clinical Sciences Source Type: research